Kenji Nakamura
Founding Partner · Venture
Former Stripe engineer.
[00 / nakamura voss]
We work with the companies building what comes next.
A technology and venture law firm built for founders. We understand code, term sheets, and clinical-trial protocols equally well — and we move at the speed you do.
We don't do paperwork. We architect outcomes.
// counsel as infrastructure — engineered, versioned, and shipped on your timeline
[01 / practice]
Six things we do, and do completely.
From incorporation to your Series C, we run the financing playbook so you can run the company. SAFEs, priced rounds, option pools, and the cap-table hygiene that survives diligence.
Buy-side, sell-side, and the acqui-hire in between. We negotiate the deal and de-risk the integration — IP, data, and key people included.
Patents are a strategy, not a filing cabinet. We build portfolios that map to your roadmap and hold up when a competitor — or an acquirer — comes looking.
Model licensing, training-data provenance, and EU AI Act readiness. We've read the regulation and the model card — and we know where they collide.
FDA pathways, trial protocols, and the regulatory strategy that keeps your raise and your science on the same calendar. Breakthrough designation included.
GDPR, CCPA, and the data-flow diagram your engineers actually maintain. Privacy designed into the architecture, not bolted on before launch.
[02 / team]
Lawyers who were something else first.
Anna Voss
Founding Partner · M&A
Closed her first deal at 26.
Daniela Reyes
Partner · IP Strategy
Named inventor on 4 patents.
Tobias Okonkwo
Partner · AI Governance
Ex-DeepMind policy lead.
Mei Chen
Partner · Life Sciences
Ex-Genentech research scientist.
Erik Lindqvist
Partner · Privacy
Previously at Cooley.
[03 / record]
The numbers, unrounded.
$0B
total deal value advised since 2011
| Year | Client | Matter | Value |
|---|---|---|---|
| 2025 | Series C AI infrastructure co. | Lead counsel, $340M raise | $340M |
| 2025 | Nasdaq-listed biotech | FDA Phase II protocol + licensing | $215M |
| 2024 | Public cloud platform | FTC second request, cleared | $1.1B |
| 2024 | Stealth neurotech startup | Formation + seed financing | $28M |
| 2023 | Series B fintech | Acquisition by public acquirer | $620M |
0
years in operation
$0B
advised, total
0+
portfolio companies
0
jurisdictions
[05 / clients]
Who we work with. (Anonymized.)
Series B AI infrastructure company
Nasdaq-listed biotech
Stealth-mode neurotech startup
Public cloud platform
Series A robotics company
Genomics data platform
Pre-seed developer-tools team
Late-stage fintech unicorn
Climate-tech hardware startup
Foundation model lab
Digital-health Series C
Quantum computing spinout
[06 / contact]
Let's talk.
Tell us what you're building. We reply to founders within one business day — usually a lot sooner.